Huntington Bancshares Incorporated (HBAN) Stock Price Today
Aura AI Summary
Key Stats
- $31.12BMarket Cap
- 14,089,342Volume
- FinancialsSector
- $19.2752W High
- $15.0252W Low
- 52 DaysTypical Hold Time
- $49.63BEnterprise Value
- 4.02%Div Yield
- 0% Sell | 100% BuyTrading Activity
Track Huntington Bancshares Incorporated (HBAN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Huntington Bancshares Incorporated has traded between a low of $15.02 and a high of $19.27, highlighting its annual price range. Buy and sell Huntington Bancshares Incorporated shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Most Recent News
AI infrastructure spending to reach $3-4 trillion by 2030, says Nvidia's Jensen Huang.
Nvidia CEO Jensen Huang has reaffirmed his long-standing forecast that global spending on AI infrastructure will surge to between $3 trillion and $4 trillion by 2030. This projection highlights the massive growth potential in the AI sector, driven by...

Social Security trust fund faces insolvency by 2032, risking 22% benefit cuts for retirees.
The Social Security Administration Commissioner Frank Bisignano confirmed that while the program will last another 90 years, its main trust fund is projected to be depleted by 2032. This insolvency would force automatic benefit cuts, estimated at aro...

Stocks fall sharply as Syndax trial fails and Six Flags faces fatal incident closure
On October 13, 2026, several stocks including Adlai Nortye, Omada Health, Syndax Pharmaceuticals, Six Flags, and Immunic saw significant declines. Syndax dropped 15.7% after its Phase 2 trial for a lung disease drug failed, leading to halted developm...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.